Evidence shows insulin resistance (IR) is preceding and central to the development of T2DM, IR being defined physiologically as a state of low response in insulin-targeting tissues to high physiological insulin levels preceding non-physiologic elevated plasma glucose levels, which is the primary clinical symptom of T2DM [54,55,56]. This evidence concerns the gene INS and type 2 diabetes mellitus.